Skip to content
- EVAX: Evaxion Approaches a Cancer-Vaccine Data Test
- SAFX: A Merger and Production Progress Give XCF’s Rebound a Story to Test
- XLAB: An $8.2 Million Nvidia-Server Deal Gives the Rally a Concrete Catalyst
- JAGX: A Special Stock Dividend Makes Jaguar’s Rally More Complicated Than It Looks
- JRVR: The Case for James River Depends on Trust in Its Reserves
- BZUN: Baozun’s Return to Profit Gives Its Turnaround Substance
- BTE: Cash Flow and Buybacks Build a Case for Baytex
- AMBP: Improving Earnings and a Potential Sale Put Ardagh in Focus
- Schwab Attracts $190.4 Billion: Client Assets Are Not Company Revenue
- Costco Declares a $1.47 Dividend: What the Payout Actually Means
